Tag: Taxol
Articles
- Breast cancer patients who gain weight after diagnosis have worse prognosis
- How to optimize your breast cancer diet
- Latest research concerning side effects of chemotherapy
- Latest research on factors influencing Taxol (paclitaxel) effectiveness
- What should breast cancer patients eat during Taxol (paclitaxel) chemotherapy?
News
- Apigenin increases effectiveness of Taxol chemotherapy
- Beta-carotene, vitamin A and vitamin E do not reduce risk of breast cancer?
- DIM from broccoli and other brassica vegetables prevents metastasis in mice
- Fish oil component can increase survival time for Stage IV breast cancer patients
- Fish oil promotes breast cancer cell death
- Garlic compound prevents cell progression to breast cancer
- Green tea polyphenol EGCG slows development of tamoxifen resistance
- Muscle and joint pain are common during taxane chemotherapy for breast cancer
- Resistance to Taxol chemotherapy reversed in breast cancer cells in the laboratory
- Resveratrol increases the effectiveness of Taxol in triple negative cells
- Survival times for metastatic breast cancer have been improving
- The beta blocker propranolol increases the effectiveness of Taxol
- The yellow vegetable pigment luteolin induces breast cancer cell death
- Turmeric component curcumin inhibits breast cancer cell proliferation
Foods
- apples blueberries broccoli brussels sprouts cabbage cauliflower celery cranberries grapes green tea greens herring and sardines horseradish kale mackerel mustard olives and olive oil onions and garlic parsley pears salmon turmeric
Studies
- (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma
- 3,3' -diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells
- Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells
- Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells
- Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo
- Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model
- Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-[kappa]B in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model
- Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation
- Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
- Effects of resveratrol on paclitaxel-sensitive and -resistant triple negative breast cancer cells
- Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer
- EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein
- Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin
- Evaluation of the Antiproliferative Effects of Essiac™ on In Vitro and In Vivo Models of Prostate Cancer Compared to Paclitaxel
- Exogenous supplementation with [omega]-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells
- Fifteen-year trends in metastatic breast cancer survival in Greece
- Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
- Late pancreatic toxicity in patients with breast cancer after taxane-anthracycline-based neoadjuvant and adjuvant chemotherapy
- Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer
- Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer
- Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy
- Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer
- Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
- Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane
- Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells
- The direct efficiency of the different modes of scheme “paclitaxel + caelyx" in the treatment of the patients having inflammatory breast cancer
- The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer
- Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis
- Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol